â??Randomized controlled clinical trial to study the efficacy OF Chandraprabha vati in PCOS.â??

iranjan Ashok Dumbare0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•1.Patients of age group 19-35 years.
•2.Diagnosed cases of PCOS (Rotterdam Criteria) Any 2/3
•a)Hyperandrogenism (Clinical or Biochemical)
•b)Oligomenorrhea (Menstrual cycle > 35days)/ Secondary Amenorrhea (Menstrual cycle > 90 days but <180 days)
•c) USG findingsâ?? PCO features on USG i.e. Peripherally arranged Antral Follicle Count >12 with thickened stroma in Ovaries And OR Ovarian Volume >10 cm3 in Unilateral or Bilateral ovaries.
•3.Both Unmarried and Married patients of PCOS.

•1.Patients of age group < 19 yrs and > 35 yrs.
•2.Patients showing signs and symptoms other than PCOS.
•3.Patients having any other disease causing Oligomenorrhea & Anovulation excluding PCOS on above criteria i.e.Hypogonadotrophic Hypogonadism, Premature Ovarian Failure.
•4.Patients suffering from a) Congenital Adrenal Hyperplasia b) Severe Insulin resistance(Insulin dependant Diabetes Mellitus) c)Androgen secreting Ovarian & Adrenal tumors d)Thyroid abnormalities e) Cushingâ??s syndrome f)Cardiac disease g) Hyperprolactenemia
•5.Patients with any organic lesions of Reproductive Tract like TB, Ca, Congenital anomalies, any other pelvic pathologies.
•6.A current or previous (within 3 months) use of OC Pills, Glucocorticoids, Antiandrogens, Antidiabetics, Antiobesity drugs or any Hormonal Therapy.

发起方

iranjan Ashok Dumbare